Standalone numbers ekdum solid!
Dekho, company ne khud ke hisaab se (standalone basis par) Q3 FY26 mein โน169.66 crore ka revenue kamaya, jo pichle saal se 21.95% zyada hai. Aur Net Profit toh ekdum โน3.38 crore ho gaya, matlab 64.08% ka bhari jump! Yahi nahi, poore 9 mahine (9MFY26) mein toh PAT 103.46% badhkar โน253.1 crore ho gaya. Standalone EPS bhi โน1.68 se โน12.65 tak pahunch gaya. Aise lag raha tha ki sab kuch mast chal raha hai.
Par CARE ki D rating ne uda diye hosh!
Magar, CARE Ratings ne company ko D rating de di hai. Iska matlab hai ki company abhi debt pay karne mein struggle kar rahi hai ya default hone ka risk hai. Ye ek bahut badi red flag hai. Iske baad hi company ke overall financial health par sawaal uth rahe hain.
Debt kam karne ki koshish toh hai...
Company ne debt kam karne ki koshish zarur ki hai. March 2025 mein jo overdue debt โน296.7 crore tha, woh December 2025 tak โน142.18 crore ho gaya. Standalone Debt-to-Equity ratio bhi 39.25 se ghata kar 1.99 kar diya hai. ISCR bhi 12.46 hai jo achha dikh raha hai. Yeh sab positive signs hain operational side se.
Lekin Consolidated picture thodi alag hai.
Consolidated basis par dekhein toh Q3 FY26 mein revenue 14.36% badhkar โน32.01 crore hua, par PAT 0.28% gir gaya. 9MFY26 mein consolidated PAT 43.51% badha tha, par revenue sirf 7.92% bada tha. Matlab, overall company ki profitability mein kuch dikkatein ho sakti hain.
Aage kya hoga? Investors ko kya dekhna chahiye?
Sabse badi chinta company ka debt time par pay karna hai, jiska proof CARE D rating hai. Share price ka warrant conversion price se neeche hona bhi future funding ke liye problem ban sakta hai. Company abhi NARCL ke saath MRA par kaam kar rahi hai aur lenders se baat kar rahi hai. Investors ko in debt repayment plans aur rating mein aane wale koi bhi changes par nazar rakhni chahiye. Governance ke liye independent directors ka re-appointment hua hai, par financial red flags ko ignore nahi kar sakte.